ArticleNucleic acids research2026
Enhancing the performance and interpretability of epigenetic clocks.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Epigenetic clocks based on DNA methylation (DNAm) accurately predict age, but their biological underpinnings remain unclear. One primary mechanism by which DNAm might influence gene regulation is by modulating transcription factor binding activity. This study investigates the regulatory potential of predictive CpGs in established epigenetic clocks. Our analysis reveals that generally most CpGs used by epigenetic clocks do not overlap known transcription factor binding sites (TFBS), indicating that clock accuracy is not primarily driven by changes in TF binding dynamics. However, analysis of CpGs within TFBSs identifies key transcription factors potentially involved in aging, including ZBED1, NFE2, and CEBPB, which are enriched for age-associated CpGs, while RELA, IKZF1, and STAT3 significantly protected against methylation changes. Leveraging TFBS-associated and age-correlated CpGs, combined with noise-stabilizing feature engineering steps, we developed an alternative TFMethyl Clock model that provides competitive predictions of chronological age. Age-predictive CpGs selected by our model enrich for target genes involved in interleukin-1β production and fatty-acid metabolism, while being enriched at TFBSs of NR2C2. Furthermore, approximately three-fourths of these target genes exhibit significant age-related changes, suggesting deeper insights into possible methylation-driven aging processes. Our findings demonstrate that incorporating regulatory information into epigenetic clocks may provide mechanistic insights into the aging process while improving the interpretability and predictive power.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.